Physician profile
Vadim Levin
NPI 1073569158
$13,824.99
in general payments reported to CMS, 2019-2025
24 companies · $436 in 2025
The $436 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,431 · 2020: $525 · 2021: $899 · 2022: $1,216 · 2023: $594 · 2024: $2,725 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,725 · Travel and Lodging: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,724.92 |
| Travel and Lodging | $1,029.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,164.22 | 2019-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Pfizer INC. | $880.86 | 2019-2024 | |
| Medtronic, INC. | $549.87 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Pulseselect |
| Janssen Pharmaceuticals, INC | $491.27 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $254.45 | 2019-2024 | Lifevest |
| Abbott Laboratories | $231.35 | 2019-2025 | Jot Dx, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $192.52 | 2019-2025 | Eliquis |
| Biosense Webster, INC. | $181.63 | 2019-2024 | Qdot Micro Catheter, Carto 3 |
| Atricure, INC. | $173.76 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $99.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.25 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $80.96 | 2022 | |
| Medtronic Vascular, INC. | $63.27 | 2020 | |
| Novartis Pharmaceuticals Corporation | $61.24 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $56.25 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $51.30 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $40.96 | 2020-2023 | Onpattro |
| Corcym INC | $34.56 | 2022 | |
| Lantheus Medical Imaging, INC. | $32.33 | 2021 | |
| Chiesi USA, INC. | $25.79 | 2020 | |
| Novo Nordisk INC | $24.96 | 2024 | Wegovy |
| Amgen INC. | $21.80 | 2023 | Repatha |
| Esperion Therapeutics, INC. | $13.89 | 2024 | Nexletol |
| Siemens Medical Solutions USA, INC. | $13.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vadim Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.